ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia.,
Maes, Tamara, Mascaró Cristina, Tirapu Iñigo, Estiarte Angels, Ciceri Filippo, Lunardi Serena, Guibourt Nathalie, Perdones Alvaro, Lufino Michele M. P., Somervaille Tim C. P., et al.
, Cancer Cell, 2018 Mar 12, Volume 33, Issue 3, p.495-511.e12, (2018)
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.,
Fontan, Lorena, Qiao Qi, Hatcher John M., Casalena Gabriella, Us Ilkay, Teater Matt, Durant Matt, Du Guangyan, Xia Min, Bilchuk Natalia, et al.
, J Clin Invest, 2018 Oct 01, Volume 128, Issue 10, p.4397-4412, (2018)